test

Jim Harding

@Propel Bio Management, Llc

Latest period2024 - Q3ReportedManaged Assets$172.411MTotal holdings21
Assets growth rate11.82%Assets growth rate (2-Q avg)0.79%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Propel Bio Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 21 positions.

Assets under management

The assets under management (AUM) of Propel Bio Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 172.411M in assets, with a quarterly growth rate of 11.82% and a 2-quarter average growth rate of 0.79%. The portfolio is managed by Jim Harding, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ABEOAbeona Therapeutics Inc
Recent Activity
Decreased -50%
2.29%
$3.944M
624,022 shares@ $6.32 avg price
KYMRKymera Therapeutics Inc
Recent Activity
1.55%
$2.667M
56,359 shares@ $47.33 avg price
SNDXSyndax Pharmaceuticals In
Recent Activity
Increased 60.06%
1.49%
$2.565M
133,259 shares@ $19.26 avg price
KURAKura Oncology Inc
Recent Activity
1.48%
$2.54M
130,000 shares@ $19.54 avg price
ZVRAZevra Therapeutics Inc
Recent Activity
New Position
0.73%
$1.248M
179,874 shares@ $6.95 avg price
2824⤦Eiger Biopharmaceuticals
Recent Activity
0.73%
$1.244M
146,381 shares@ $8.51 avg price
ATHAAthira Pharma Inc
Recent Activity
0.39%
$665,785
1.493M shares@ $0.45 avg price
CMPSCompass Pathways Ltd
Recent Activity
New Position
0.3%
$504,000
80,000 shares@ $6.3 avg price
VRCAVerrica Pharmaceuticals I
Recent Activity
Decreased -18.82%
0.3%
$500,159
344,937 shares@ $1.46 avg price
MATPFMaat Pharma Saca
Recent Activity
New Position
0.02%
$17,786
2,397 shares@ $7.43 avg price